| Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database C Lacroix, F Kheloufi, F Montastruc, Y Bennis, V Pizzoglio, J Micallef Journal of the Neurological Sciences 398, 196-201, 2019 | 54 | 2019 |
| Psychiatric disorders after starting dolutegravir: report of four cases F Kheloufi, J Allemand, S Mokhtari, A Default Aids 29 (13), 1723-1725, 2015 | 49 | 2015 |
| Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect F Kheloufi, Q Boucherie, O Blin, J Micallef Aids 31 (12), 1775-1777, 2017 | 27 | 2017 |
| Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis F Kheloufi, D Frankel, E Kaspi, M Lepelley, M Mallaret, Q Boucherie, ... Therapies 73 (3), 273-281, 2018 | 19 | 2018 |
| Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre? F Kheloufi, A Default, F Rouby, D Laugier-Castellan, M Boyer, ... European Journal of Clinical Pharmacology 73, 1009-1018, 2017 | 14 | 2017 |
| Investigating patient narratives posted on Internet and their informativeness level for pharmacovigilance purpose: the example of comments about statins F Kheloufi, A Default, O Blin, J Micallef Therapies 72 (4), 483-490, 2017 | 13 | 2017 |
| How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs) A Dutilleul, J Morel, C Schilte, O Launay, B Autran, JM Behier, T Borel, ... Therapies 74 (1), 131-140, 2019 | 9 | 2019 |
| Abuse and misuse of second‐generation antipsychotics: an analysis using VigiBase, the World Health Organisation pharmacovigilance database S Roy, R Charreteur, M Peries, F Kheloufi, C Eiden, N Nagot, ... British Journal of Clinical Pharmacology 88 (10), 4646-4653, 2022 | 5 | 2022 |
| Intérêt de la mise à disposition de la naloxone auprès des usagers de drogues pour le traitement d’urgence de surdosage d’opioïdes E Frauger, F Kheloufi, Q Boucherie, E Monzon, L Jupin, N Richard, ... Therapies 73 (6), 511-520, 2018 | 5 | 2018 |
| Comment on “Patient reporting in the EU: analysis of EudraVigilance data” F Kheloufi, A Default, F Rouby, O Blin, J Micallef Drug Safety 40, 935-936, 2017 | 5 | 2017 |
| Interest of take-home naloxone for opioid overdose E Frauger, F Kheloufi, Q Boucherie, E Monzon, L Jupin, N Richard, ... Therapie 73 (6), 511-520, 2018 | 4 | 2018 |
| Urinary retention associated with aripiprazole: Report of a new case and review of the literature MG Boyer, F Kheloufi, J Denis, J Micallef, M Milh Therapie 73 (3), 287-289, 2018 | 4 | 2018 |
| Comment améliorer l’acceptabilité vaccinale (évaluation, pharmacovigilance, communication, santé publique, obligation vaccinale, peurs et croyances) A Dutilleul, J Morel, C Schilte, O Launay, B Autran, JM Béhier, T Borel, ... Therapies 74 (1), 119-129, 2019 | 3 | 2019 |
| Informativité des déclarations de pharmacovigilance en médecine générale en France X Humbert, J Jacquot, J Alexandre, M Sassier, N Robin, C Pageot, ... Santé Publique 31 (4), 561-566, 2019 | 3 | 2019 |
| Sharing experience with adverse drug reactions on internet: Which adverse drug reactions involving statins are described by patients on internet-based-forums? F Kheloufi, MJ Jean-Pastor FUNDAMENTAL & CLINICAL PHARMACOLOGY 28, 56-56, 2014 | 3 | 2014 |
| Completeness of pharmacovigilance reporting in general medicine in France X Humbert, J Jacquot, J Alexandre, M Sassier, N Robin, C Pageot, ... Sante Publique 31 (4), 561-566, 2019 | 2 | 2019 |
| Quantitative System Pharmacology (QSP): An Integrative Framework for paradigm change in the treatment of the first-episode schizophrenia F Gaillard-Bigot, XY Zendjidjian, F Kheloufi, C Casse-Perrot, ... L'encephale 44 (6), S34-S38, 2018 | 2 | 2018 |
| Perampanel-associated self-harm ideation after dosage increase F Kheloufi, A Default, B Perrouty, O Blin, J Micallef European journal of clinical pharmacology 74, 243-244, 2018 | 2 | 2018 |
| Third nerve palsy after influenza vaccination in inflammatory bowel disease (IBD) F Rouby, F Kheloufi, J Micallef Therapie 72 (6), 695-697, 2017 | 2 | 2017 |
| A curious delayed photosensitivity reaction in a patient treated with pirfenidone for idiopathic pulmonary fibrosis D Leroux, F Kheloufi, K Alagha, A Default, MJ Jean-Pastor FUNDAMENTAL & CLINICAL PHARMACOLOGY 29, 38-38, 2015 | 2 | 2015 |
olivier blinprof marseilleVerified email at ap-hm.fr
olivier blinprof marseilleVerified email at ap-hm.fr